Key Points
- President Dawn Christine Maroney sold 228,152 shares on Jan. 6 at an average price of $21.33 for $4,866,482.16, reducing her holding by 17.75% to 1,057,015 shares (≈$22.55M).
- The Jan. 6 sale is part of a string of recent disposals by Maroney (including 100,000 shares on Jan. 2), amounting to roughly 328,152 shares (~$6.87M) in those transactions, and other executives also trimmed positions — moves often viewed by investors as profit‑taking.
- Fundamentals show mixed signals: Alignment reported strong revenue growth (+43.5% YoY) and an October quarter EPS beat ($0.02 vs. -$0.01), while the stock trades near its 52‑week high (~$21.30) but consensus still expects a negative full‑year EPS and the P/E is negative.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Christopher Joyce sold 10,611 shares of Alignment Healthcare stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $20.03, for a total value of $212,538.33. Following the sale, the insider owned 297,088 shares of the company's stock, valued at approximately $5,950,672.64. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Alignment Healthcare Trading Up 1.4%
NASDAQ ALHC opened at $21.30 on Wednesday. The stock has a market cap of $4.26 billion, a PE ratio of -177.50, a PEG ratio of 6.03 and a beta of 1.16. Alignment Healthcare, Inc. has a 12 month low of $11.35 and a 12 month high of $21.65. The company's 50-day moving average price is $18.50 and its 200-day moving average price is $16.43. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.03. The company had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The firm's revenue for the quarter was up 43.5% on a year-over-year basis. During the same quarter last year, the business posted ($0.14) EPS. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.
Alignment Healthcare News Roundup
Here are the key news stories impacting Alignment Healthcare this week:
- Positive Sentiment: Recent operating results show revenue strength and an EPS beat in the October quarter (revenue ~$993.7M, +43.5% YoY; EPS $0.02 vs. consensus -$0.01), which underpins investor confidence in growth and helps explain upward price pressure. MarketBeat: ALHC
- Neutral Sentiment: Benzinga published an analyst-coverage roundup on Alignment that may affect near-term views depending on upgrades/price-target changes; check the article for analyst moves that could amplify today's trading. Benzinga: Where Alignment Healthcare Stands With Analysts
- Negative Sentiment: Multiple insider sales were disclosed this week — a potential near-term headwind as investors often read large executive stock sales as profit-taking or reduced insider conviction. Notable filings: President Dawn Maroney sold 100,000 shares on Jan 2 (~$2.00M at $20.03) and 228,152 shares on Jan 6 (~$4.87M at $21.33); combined sales ≈328,152 shares (~$6.87M). Filings: Dawn Maroney Form 4. Other insiders also trimmed positions: Christopher J. Joyce sold 10,611 shares (~$212.5k) (Joyce Form 4) and Hyong Kim sold 16,506 shares (~$352k) (Kim Form 4). These sales may temper gains, especially since trades occurred near recent highs.
Institutional Investors Weigh In On Alignment Healthcare
Institutional investors have recently added to or reduced their stakes in the stock. Larson Financial Group LLC bought a new position in Alignment Healthcare in the third quarter worth about $33,000. SBI Securities Co. Ltd. grew its position in shares of Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company's stock worth $42,000 after buying an additional 2,970 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Alignment Healthcare by 83.8% during the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company's stock worth $43,000 after acquiring an additional 987 shares in the last quarter. KBC Group NV purchased a new stake in Alignment Healthcare during the second quarter valued at approximately $44,000. Finally, Signaturefd LLC boosted its stake in Alignment Healthcare by 142.6% in the second quarter. Signaturefd LLC now owns 3,768 shares of the company's stock valued at $53,000 after acquiring an additional 2,215 shares in the last quarter. Institutional investors own 86.19% of the company's stock.
Analysts Set New Price Targets
Several research analysts recently issued reports on ALHC shares. Barclays increased their price objective on Alignment Healthcare from $13.00 to $18.00 and gave the stock an "equal weight" rating in a research note on Friday, October 31st. UBS Group upped their target price on Alignment Healthcare from $17.00 to $18.00 and gave the stock a "neutral" rating in a report on Friday, October 31st. KeyCorp restated an "overweight" rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Piper Sandler lifted their price objective on Alignment Healthcare from $20.00 to $30.00 and gave the company an "overweight" rating in a report on Tuesday. Finally, Zacks Research lowered shares of Alignment Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, October 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $21.25.
View Our Latest Stock Analysis on ALHC
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
